tipifarnib has been researched along with thiophenes in 1 studies
| Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (thiophenes) | Trials (thiophenes) | Recent Studies (post-2010) (thiophenes) |
|---|---|---|---|---|---|
| 309 | 92 | 94 | 17,012 | 1,961 | 8,038 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, M; Lee, DW; Lee, HN; Lee, W | 1 |
1 other study(ies) available for tipifarnib and thiophenes
| Article | Year |
|---|---|
Dual inhibition of FOXM1 and its compensatory signaling pathway decreased the survival of ovarian cancer cells.
Topics: Acetophenones; Benzopyrans; Cell Line, Tumor; Cell Survival; Female; Forkhead Box Protein M1; GTP Phosphohydrolases; Humans; Membrane Proteins; Ovarian Neoplasms; Pyridines; Quinazolines; Quinolones; Signal Transduction; Thiophenes | 2021 |